Abstract
Background and Aims : Bempedoic acid, an inhibitor of ATP citrate lyase, reduces low-density lipoprotein cholesterol (LDL-C) and since 2020 has become an additional treatment option to reach the LDL-C treatment goal. The aim of this analysis is to provide new data of side effects and efficacy of bempedoic acid in a “real-world” cohort.
Full Text
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call